دورية أكاديمية
Enthesitis Related Arthritis in a Longitudinal Southeast Asian Registry: High Prevalence of HLA-B27, Different Sacroiliitis Risk Factors and Less Common Drug-Free Remission.
العنوان: | Enthesitis Related Arthritis in a Longitudinal Southeast Asian Registry: High Prevalence of HLA-B27, Different Sacroiliitis Risk Factors and Less Common Drug-Free Remission. |
---|---|
المؤلفون: | Arkachaisri T; Rheumatology and Immunology Service, Department of Pediatric Subspecialties, KK Women's and Children's Hospital, Singapore 229899, Singapore.; Duke-NUS Medical School, Pediatric Academic Clinical Program, Singapore 169857, Singapore., Teh KL; Rheumatology and Immunology Service, Department of Pediatric Subspecialties, KK Women's and Children's Hospital, Singapore 229899, Singapore., Book YX; Rheumatology and Immunology Service, Department of Pediatric Subspecialties, KK Women's and Children's Hospital, Singapore 229899, Singapore., Hoh SF; Division of Nursing, KK Women's and Children's Hospital, Singapore 229899, Singapore., Gao X; Division of Nursing, KK Women's and Children's Hospital, Singapore 229899, Singapore., Das L; Rheumatology and Immunology Service, Department of Pediatric Subspecialties, KK Women's and Children's Hospital, Singapore 229899, Singapore. |
المصدر: | Journal of clinical medicine [J Clin Med] 2021 Feb 03; Vol. 10 (4). Date of Electronic Publication: 2021 Feb 03. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101606588 Publication Model: Electronic Cited Medium: Print ISSN: 2077-0383 (Print) Linking ISSN: 20770383 NLM ISO Abbreviation: J Clin Med Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Original Publication: Basel, Switzerland : MDPI AG, [2012]- |
مستخلص: | Objective . To describe the clinical characteristics, predictors and treatment of children with Enthesitis Related Arthritis (ERA) in a Singapore longitudinal cohort over 11 years. Methods . ERA patients were recruited from our registry (2009-2019). Nonparametric descriptive statistics including median (interquartile range, IQR) were used to describe data. Kaplan-Meier survival and logistic/Cox regression analyses were used to estimate the probabilities and determine predictors of clinical variables, respectively. The significance level was set at <0.05. Results . One hundred and forty-six ERA patients (87% male, 82% Chinese) were included. Median onset age was 11.9 years (IQR 9.4-14.0) and median disease duration was 4.9 years (IQR 2.6-8.3). Family history of Human Leukocyte Antigen (HLA)-B27 associated diseases was positive in 7.5%. Acute uveitis occurred in 3.4%. Oligoarthritis was present in 89.7%. Hip, knee and ankle joints were among the most common joints involved. One-fourth had enthesitis at diagnosis (Achilles tendon entheses, 82.9%). Sacroiliitis occurred in 61%. Probabilities of sacroiliitis development were 0.364, 0.448 and 0.578 at 1, 2 and 5 years after onset, respectively. Negative HLA-B27, female, older age at onset and hip arthritis at diagnosis were associated with shorter time for sacroiliitis development ( p = 0.001-0.049). Methotrexate (MTX) remained the most common disease modifying anti-rheumatic drug (DMARD) used (77.4%). However, 77.9% required anti-TNF (aTNF) therapy secondary to MTX failure. Among MTX-treated sacroiliitis patients, 85.3% failed, requiring aTNF, as compared to 63.2%patients without axial disease. Longer duration to diagnosis ( p = 0.038) and MTX use ( p = 0.007) predicted aTNF therapy. None had joint deformity. Conclusions . This study underscores differences in ERA clinical characteristics, predictors and treatment responses. Our ERA population had many unique findings but good functional outcomes. |
References: | J Microbiol Immunol Infect. 2013 Aug;46(4):288-94. (PMID: 22727543) Curr Rheumatol Rep. 2017 May;19(5):26. (PMID: 28386763) Clin Rheumatol. 2020 Nov;39(11):3455-3464. (PMID: 32418038) Rheumatol Int. 2016 Oct;36(10):1407-11. (PMID: 27411808) Arthritis Care Res (Hoboken). 2018 Feb;70(2):303-308. (PMID: 28426894) Pediatr Int. 2020 Sep 24;:. (PMID: 32969552) Arthritis Rheum. 2006 Nov;54(11):3573-82. (PMID: 17075863) Pediatr Rheumatol Online J. 2019 Aug 23;17(1):58. (PMID: 31443722) Rheumatology (Oxford). 2020 Dec 1;59(12):3727-3730. (PMID: 32402087) Rheumatology (Oxford). 2017 Mar 1;56(3):390-398. (PMID: 27994096) Ann Rheum Dis. 2016 Nov;75(11):1958-1963. (PMID: 26768408) J Rheumatol. 2004 Feb;31(2):390-2. (PMID: 14760812) Arthritis Rheum. 2004 Jul;50(7):2191-201. (PMID: 15248217) Arthritis Care Res (Hoboken). 2011 Jul;63(7):929-36. (PMID: 21717596) Arthritis Rheum. 2005 Jun 15;53(3):445-51. (PMID: 15934110) J Rheumatol. 2010 Nov;37(11):2395-401. (PMID: 20810515) N Engl J Med. 1992 Apr 16;326(16):1043-9. (PMID: 1549149) PLoS One. 2015 Jun 01;10(6):e0128979. (PMID: 26030261) Lancet Child Adolesc Health. 2019 Apr;3(4):255-263. (PMID: 30819662) Arthritis Rheum. 2007 Jun;56(6):1974-84. (PMID: 17530723) Clin Exp Rheumatol. 2015 Nov-Dec;33(6):931-5. (PMID: 26314893) Clin Exp Rheumatol. 2011 Jan-Feb;29(1):111-6. (PMID: 21269582) Arthritis Res Ther. 2017 May 2;19(1):84. (PMID: 28464909) Pediatr Rheumatol Online J. 2018 Apr 2;16(1):21. (PMID: 29609643) Arthritis Rheum. 1998 Mar;41(3):381-91. (PMID: 9506564) Tissue Antigens. 1997 Jan;49(1):67-9. (PMID: 9027969) Clin Rheumatol. 2020 Nov 24;:. (PMID: 33236179) Curr Rheumatol Rep. 2013 Oct;15(10):362. (PMID: 23990399) Int J Rheum Dis. 2016 Dec;19(12):1342-1350. (PMID: 26176300) Pediatr Rheumatol Online J. 2013 Mar 15;11(1):11. (PMID: 23497068) Open Access Rheumatol. 2019 Jan 25;11:19-31. (PMID: 30774484) J Rheumatol. 2013 May;40(5):725-31. (PMID: 23547219) |
معلومات مُعتمدة: | ILAR (2011) International League of Association for Rheumatology; 2011 National Arthritis Foundation of Singapore |
فهرسة مساهمة: | Keywords: Singapore; Southeast Asia; enthesitis-related arthritis; juvenile idiopathic arthritis; predictors; treatment |
تواريخ الأحداث: | Date Created: 20210206 Latest Revision: 20210303 |
رمز التحديث: | 20221213 |
مُعرف محوري في PubMed: | PMC7913299 |
DOI: | 10.3390/jcm10040568 |
PMID: | 33546269 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2077-0383 |
---|---|
DOI: | 10.3390/jcm10040568 |